Location History:
- Cambridge, MA (US) (2012)
- Belmont, MA (US) (2013)
- Waltham, MA (US) (2016)
Company Filing History:
3 out of 255 
1 out of 26 
Years Active: 2012-2016
Title: Innovations and Contributions of Hans K Erickson
Introduction
Hans K Erickson is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of oncology through his innovative patents. With a total of 3 patents, Erickson has focused on developing targeted therapies that address complex tumor environments.
Latest Patents
One of Erickson's latest patents involves compounds that target the fibroblast growth factor receptor-3 (FGFR3). This invention provides conjugates that consist of a drug moiety agent and a cell binding agent specifically designed to target human FGFR3. These conjugates are intended for therapeutic use, delivering a potent cytotoxin directly into the targeted cells. This approach offers significant advantages over existing therapies by providing targeted tumor treatment and bystander activity to adjacent cells in a moderately expressed oncology receptor.
Another important patent addresses the elimination of heterogeneous or mixed cell populations in tumors. This method describes techniques for killing or inhibiting tumors by selectively targeting a unique ligand expressed on specific cell populations. The therapeutic use of these conjugates allows for the delivery of cytotoxic drugs to kill both targeted and non-targeted cells, effectively eliminating the tumor.
Career Highlights
Throughout his career, Hans K Erickson has worked with prominent companies in the biotechnology sector, including Immunogen, Inc. and Imclone LLC. His work has significantly advanced the understanding and treatment of cancer, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Erickson has collaborated with esteemed colleagues such as Viktor S Goldmakher and Robert J Lutz. These partnerships have further enriched his research and development efforts, leading to groundbreaking advancements in targeted cancer therapies.
Conclusion
Hans K Erickson's contributions to the field of oncology through his innovative patents demonstrate his dedication to advancing medical science. His work continues to influence the development of targeted therapies that aim to improve the lives of patients facing complex tumor challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.